"hypothesis": we have no idea, but we think we could do this.
"in the near future": the word near should probably be ignored. when dealing with pharmaceuticals you either have something or you do not.
the best thing the company could do would be to take the suspension formulation, which hopefully increases absorption, and sell that to a pharma company. there is too much bs associated with the FDA and broken regulation of pharmaceuticals in this country for it to be a good use of Fuse's time and resources.
the strength of this company is in the supplement market where regulation is lax and the market is exploding.
Market Data 
Markets 
AI
